Hepatotoxicity After Desflurane Anesthesia

Amaç & Hipotez:Halogenated inhalational anesthetics, which have been used for the induction and maintenance of general anesthesia, can cause liver injury, ranging from temporary transaminase elevation to hepatic necrosis.

📊

Temel Bulgular & Veri:It is rare but causes serious morbidity and mortality.

💡

Sonuç & Katkı:Herein we present a case of severe transaminase elevation after using desflurane anesthesia for obesity surgery.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Halogenated inhalational anesthetics, which have been used for the induction and maintenance of general anesthesia, can cause liver injury, ranging from temporary transaminase elevation to hepatic necrosis. It is rare but causes serious morbidity and mortality. Herein we present a case of severe transaminase elevation after using desflurane anesthesia for obesity surgery.

🔖

Bu Makaleye Atıf Yap

ASLAN, E., GÖNEN, C., SALTÜRK, A., GÜZELBULUT, F. (2018). Hepatotoxicity After Desflurane Anesthesia. Haydarpaşa Numune Medical Journal, Cilt: 58 - Sayı: 4, 224–226. https://ajindex.com/articles/197350

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

Safari S, Motavaf M, Seyed Siamdoust SA, Alavian SM. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J 2014;16:e20153. [CrossRef ] 2. Lin J, Moore D, Hockey B, Di Lernia R, Gorelik A, Liew D, et al. Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients. Liver Int 2014;34:576–82. [CrossRef ] 3. Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther 2010;17:219–22. [CrossRef] 4. Eghtesadi-Araghi P, Sohrabpour A, Vahedi H, Saberi-Firoozi M. Halothane hepatitis in Iran: a review of 59 cases. World J Gastroenterol. 2008 Sep 14;14:5322–6. [CrossRef ] 5. Walton B, Simpson BR, Strunin L, Doniach D, Perrin J, Appleyard AJ. Unexplained hepatitis following halothane. Br Med J 1976;1:1171–6. [CrossRef ] 6. Tung D, Yoshida EM, Wang CS, Steinbrecher UP. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth 2005;52:133–6. [CrossRef ] 7. Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM. Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon 2011;11:3–6. 8. Anderson JS, Rose NR, Martin JL, Eger EI, Njoku DB. Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth Analg 2007;104:1452–3. [CrossRef ] 9. Lo SK, Wendon J, Mieli-Vergani G, Williams R. Halothaneinduced acute liver failure: continuing occurrence and use of liver transplantation. Eur J Gastroenterol Hepatol 1998;10:635–9. 10. Moore DH, Benson GD. Prolonged halothane hepatitis. Prompt resolution of severe lesion with corticosteroid therapy. Dig Dis Sci 1986;31:1269–72. [CrossRef ]